Follow The Filings

ACMR ACM Research

ACM Research earnings company data as of 1:01 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.41 — —
Rev — — —

Insider trades

Open-market buys and sales by ACMR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACMR insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $51.2M sold by 8 insiders under 10b5-1 plans
  1. David H Wang See Remarks
    Planned sale
    $10.6M 140,000 shares at $75.93 15% of stake
    Traded Sep 8–9 Filed Sep 10
  2. Mark McKechnie See Remarks
    Planned sale
    $4.3M 55,199 shares at $77.27 98% of stake
    Traded Aug 20 Filed Aug 21
  3. Haiping Dun Director
    Planned sale
    $406K 5,000 shares at $81.13 100% of stake
    Traded Aug 18 Filed Aug 20
  4. Sotheara Cheav See remarks
    Planned sale
    $1.6M 18,750 shares at $84.58 16% of stake
    Traded Jun 4–5 Filed Jun 5
  5. David H Wang See Remarks
    Planned sale
    $8.8M 100,002 shares at $88.35 11% of stake
    Traded Jun 3–4 Filed Jun 5
  6. Haiping Dun Director
    Planned sale
    $331K 5,000 shares at $66.22 100% of stake
    Traded May 19 Filed May 21
  7. Charles C Pappis Director
    Planned sale
    $260K 5,000 shares at $52.00 100% of stake
    Traded Apr 17 Filed Apr 21
  8. Mark McKechnie See Remarks
    Planned sale
    $4.5M 98,551 shares at $45.58 99% of stake
    Traded Mar 12 Filed Mar 13
  9. David H Wang See Remarks
    Planned sale
    $5.2M 110,000 shares at $46.86 12% of stake
    Traded Mar 11–12 Filed Mar 13
  10. Tracy Liu Director
    Planned sale
    $2.9M 60,000 shares at $47.51 35% of stake
    Traded Mar 10–11 Filed Mar 12
  11. Haiping Dun Director
    Planned sale
    $217K 5,000 shares at $43.47 100% of stake
    Traded Mar 9 Filed Mar 11
  12. Charles C Pappis Director
    Planned sale
    $250K 5,000 shares at $50.09 100% of stake
    Traded Mar 5 Filed Mar 9
  13. Lisa Feng See remarks
    Planned sale
    $1.4M 30,000 shares at $48.04 38% of stake
    Traded Mar 5–6 Filed Mar 9
  14. Mark McKechnie See Remarks
    Planned sale
    $1.1M 31,250 shares at $34.93 97% of stake
    Traded Dec 4–8 Filed Dec 8, 2025
  15. David H Wang See Remarks
    Planned sale
    $4.4M 130,000 shares at $33.55 14% of stake
    Traded Dec 3–4 Filed Dec 5, 2025

Also filed in the last 12 months, not counted as buying or selling: 29 option exercises and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 8.01,9.01
8-K 8.01,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 8.01,9.01
8-K 5.07
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01
8-K 1.01,9.01
424B5
10-Q
8-K 2.02,9.01
DEF 14A
8-K 2.02,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
8-K 8.01,9.01
8-K 8.01,9.01
10-K
8-K 2.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.